CoMind designs and manufactures a groundbreaking non-invasive approach to brain monitoring, providing a multidimensional view of brain activity using low-powered infrared lasers. This technology aims to enhance patient safety, improve healthcare economics, and improve clinical outcomes by measuring cerebral blood flow, intracranial pressure, and autoregulation.
- Category
- Neurotechnology
- Stage
- Series A
- Employees
- 79
- HQ
- London, United Kingdom
- Founded
- 2018
- Funding
- $103M